Trial Condition(s):

Postmenopause, Hormone Replacement Therapy

Study to evaluate the effect of Angeliq® and ActivelleTM on hemostasis parameters in healthy postmenopausal women

Bayer Identifier:

91203

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
59
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design